Evidence map›Paper›PMID 42819124›Full record

ArticleFrontiers in oncology2026

Cervical cancer prevention in Riyadh: a cross-sectional analysis of sociodemographic correlates, knowledge-awareness-practice gaps, and healthcare provider influence.

Eman Alshehri, Malak AlHakeem, Remaz Abdullah Almahmoud, Aleen Abdulaziz AlKulyah, Ariam Majed Almasari, Aishah Ibrahim Boureggah, Aroub Mohammed Almahmoud, Maryam Ali Alghannam, Aseel Fahad Alsaif, Ahmed Sherif AbdelHamid Abdelwahab

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman AlshehriDepartment of Obstetrics and Gynecology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Malak AlHakeemDepartment of Obstetrics and Gynecology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Remaz Abdullah AlmahmoudCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Aleen Abdulaziz AlKulyahCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ariam Majed AlmasariCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Aishah Ibrahim BoureggahCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Aroub Mohammed AlmahmoudCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Maryam Ali AlghannamCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Aseel Fahad AlsaifCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ahmed Sherif AbdelHamid AbdelwahabDepartment of Obstetrics and Gynecology, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Cervical cancer prevention continues to pose a significant public health challenge in Saudi Arabia. This research aimed to evaluate women's knowledge, awareness, and behaviors related to cervical cancer screening and Human papillomavirus (HPV) vaccination in Riyadh, and to identify key factors influencing participation and the obstacles faced. Methods: This cross-sectional study was conducted among a diverse sample of women recruited through online platforms, institutional networks, and community-based groups. Data collection involved a structured questionnaire covering sociodemographic details, knowledge, awareness, practices, and barriers. Data analysis included descriptive statistics, gap analysis, and multivariable regression using the Statistical Package for the Social Sciences (SPSS) v28.0. Results: Awareness of Papanicolaou (Pap) smear was high at 77.8%, but actual screening participation was low at 26.7%. HPV vaccine awareness was 42.0%, yet only 9.3% had received the vaccine. Knowledge levels varied: 82.0% understood the purpose of the Pap smear, but just 20.4% knew the recommended screening intervals. The main barriers included a lack of understanding (43.4%) and limited awareness of testing locations (17.1%). Regression analysis showed that awareness of the HPV vaccine significantly predicted knowledge (β = 1.903, p < 0.001), and that advice from physicians doubled vaccination rates compared with other sources. Conclusions: A notable gap exists between awareness and practice, mainly due to knowledge deficits rather than access issues. Future efforts should focus on provider-led, behavior-oriented education to convert awareness into action and lessen the cervical cancer burden.

Indexed as

cancer epidemiologycervical cancerHPV vaccinationpap smearpreventive medicineSaudi Arabia

Identifiers

PMID42819124
PMCPMC13623620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.